- Home
- IHT vs APVO Comparison
IHT vs APVO Comparison
Compare IHT & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IHT
- APVO
- Stock Information
- Founded
- IHT 1971
- APVO 2016
- Country
- IHT United States
- APVO United States
- Employees
- IHT N/A
- APVO N/A
- Industry
- IHT Investment Bankers/Brokers/Service
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- IHT Finance
- APVO Health Care
- Exchange
- IHT Nasdaq
- APVO Nasdaq
- Market Cap
- IHT 18.2M
- APVO 21.7M
- IPO Year
- IHT N/A
- APVO N/A
- Fundamental
- Price
- IHT $1.60
- APVO $1.46
- Analyst Decision
- IHT
- APVO
- Analyst Count
- IHT 0
- APVO 0
- Target Price
- IHT N/A
- APVO N/A
- AVG Volume (30 Days)
- IHT 84.5K
- APVO 4.5M
- Earning Date
- IHT 12-15-2025
- APVO 11-10-2025
- Dividend Yield
- IHT 1.25%
- APVO N/A
- EPS Growth
- IHT N/A
- APVO N/A
- EPS
- IHT N/A
- APVO N/A
- Revenue
- IHT $7,463,789.00
- APVO N/A
- Revenue This Year
- IHT N/A
- APVO N/A
- Revenue Next Year
- IHT N/A
- APVO N/A
- P/E Ratio
- IHT N/A
- APVO N/A
- Revenue Growth
- IHT N/A
- APVO N/A
- 52 Week Low
- IHT $1.37
- APVO $1.32
- 52 Week High
- IHT $4.24
- APVO $298.00
- Technical
- Relative Strength Index (RSI)
- IHT 46.97
- APVO 42.13
- Support Level
- IHT $1.38
- APVO $1.48
- Resistance Level
- IHT $1.89
- APVO $1.57
- Average True Range (ATR)
- IHT 0.14
- APVO 0.09
- MACD
- IHT 0.01
- APVO 0.00
- Stochastic Oscillator
- IHT 44.23
- APVO 0.00
About IHT InnSuites Hospitality Trust Shares of Beneficial Interest
InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns and operates hotels, provides management services for hotels, and also provides trademark license services. The Trust is also involved in various operations incidental to the operation of hotels, such as the operation of restaurants, meeting/banquet room rentals, and the operation of a reservation system. It has one reportable segment Hotel Operations & Hotel Management Services.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.